The closing stage pulls the session together around one patient with a long list. The written territory is the whole regimen rather than one agent: interactions and duplications across classes, changes in how an aging body handles drugs, adherence as a set of practical obstacles rather than a character trait, and teaching built to survive a move between settings. Your section may print this as NR 293 or NR293; it is the same course. Chamberlain publishes no syllabi outside Canvas. The placement here is our teaching judgment from the course's catalog arc; your section's rubric decides what your week actually asks.
What NR-293 Week 8 asks for
On the afternoon a resident leaves a skilled nursing facility to live with her son, the list she takes with her runs to fourteen entries, two of which do the same job under different names, three of which are timed to meals she has not been eating consistently, and one of which was started during the hospital stay for a problem that has since resolved. Her son will be managing all of it in a kitchen where an older bottle of one of the same medications is already sitting on a shelf. The closing stage of a pharmacology course exists to make that afternoon writable.
Polypharmacy is not simply a count. It is the state in which the number of agents creates risks the individual agents do not, through three main routes. Duplication occurs when two products act on the same pathway, sometimes under a brand name and a generic name that a family does not recognize as the same thing. Interaction occurs when one agent changes how another is cleared, or when two pull the same physiologic lever until the effect overshoots. Cascade occurs when an adverse effect of one medication is treated as a new problem with a further medication, and the list grows without anyone revisiting the original cause.
Aging changes the pharmacology itself, and a strong paper says so mechanistically. Reduced renal clearance leaves more drug in the body after each dose, altered body composition changes where fat soluble agents distribute, lower plasma protein raises the unbound fraction of highly bound drugs, and a nervous system with less reserve responds more strongly to central agents. Adherence, meanwhile, is usually a practical problem: cost, packaging that cannot be opened, schedules that do not fit a day, swallowing difficulty, or simply too many bottles. Deliverables at this stage are typically a comprehensive medication review paper or a teaching plan, sometimes with a post beside it; treat a post as final copy, since posts do not reopen once submitted in Canvas.
The NR-293 Week 8 method, step by step
Six moves for writing a whole-regimen paper.
-
Group the criterion rows into regimen rows and teaching rows
Closing rubrics usually want both an analysis of the list and a plan for the person managing it. Assign paragraphs to each before drafting, because a strong analysis with a thin teaching section is the classic split score here.
-
Sort the list by lever rather than by alphabet
Group the agents by what they act on. Duplications and overlapping effects become visible immediately, and the grouping itself demonstrates the class reasoning the whole course has been building toward.
-
Name each interaction by its shared pathway
Two agents matter together when one alters the clearance of the other or when both move the same variable. Say which of those is happening rather than reporting that an interaction is listed.
-
Apply the aging changes to specific agents on the list
Reduced clearance matters most for the agents that depend on the kidney, and lower protein binding matters most for the drugs that are highly bound. Applied, not asserted.
-
Write adherence as obstacles you can name
Bottle, schedule, cost, swallowing, memory, who actually administers. Each obstacle has a practical response, and pairing them is what earns the row that most students fill with generalities.
-
Build teaching for the person who will do the work
In a transition to a family home the learner is often not the resident. Say who, say what they must recognize and report, and describe how you would confirm understanding rather than assume it.
A layout and word budget for a medication review paper
Our frame for a closing review of roughly 1,200 to 1,400 words. It is our own outline rather than anything the university publishes, and your week's criterion rows outrank it wherever the two disagree.
| Section | What belongs in it | Word target |
|---|---|---|
| The regimen, grouped | The list organized by what each agent acts on, with duplications made visible by the grouping. | 180 to 220 |
| Interactions | Each pairing named by shared pathway, with the direction the combined effect would move. | 210 to 250 |
| Age-related handling | Clearance, distribution, protein binding and central sensitivity, applied to named agents on this list. | 200 to 240 |
| Cascade check | Any entry that looks like treatment of another entry's adverse effect, with the reasoning shown. | 150 to 190 |
| Adherence obstacles | Practical barriers named individually, each paired with a response within nursing scope. | 190 to 230 |
| Teaching plan and close | The learner identified, priority points with reasons, confirmation method, and what to report. | 200 to 240 |
Sourcing craft for whole-regimen writing
Cite published criteria rather than inventing a standard. Lists of medications that warrant extra caution in older adults are maintained by professional organizations and revised on their own schedules, so name the criteria you used and give the year.
Check every interaction in a reference before writing it. A closing paper covers many pairings, and the temptation to write from memory is highest here. Attribute each one, and describe the mechanism rather than repeating a severity label.
Write teaching points with a reason and a confirmation. Instruction, rationale, and how you would know it was understood. Teach-back style confirmation is documented in health literacy literature, so cite the source rather than presenting the technique as your own.
Keep the discharge scene generic and the clinical layer separate. No names, dates, facility or family identifiers. The reconciliation itself, the administration, the teaching delivered at the bedside, documentation and clinical hours are the student's own work to perform and sign; this manual addresses only the written coursework.
Five mistakes that cost points in this week's territory
- The list transcribed rather than analyzed. Reproducing fourteen entries with a sentence each is inventory, and the closing rubric is asking for relationships between them.
- Interactions reported as severity labels. Moderate or major tells the reader nothing without the pathway and the direction of the combined effect.
- Aging changes stated but never applied. A paragraph about reduced clearance that never names which drug on this list depends on it has not done the work.
- Adherence treated as motivation. Most non-adherence is practical, and a paper that frames it as unwillingness misses every intervention available.
- Teaching aimed at the wrong learner. In a transition to family care, teaching written only for the resident ignores who will actually be handling the medications.
Before you submit
- The regimen is grouped by action rather than listed alphabetically
- Every interaction names a shared pathway and a direction
- Age-related changes are applied to specific agents on this list
- The list is checked for any prescribing cascade
- Adherence obstacles are named individually with practical responses
- The teaching plan identifies the learner and a confirmation method
Closing out NR-293?
Send the regimen and the criterion rows out of Canvas. A premium original draft comes back in 24 to 48 hours with the list grouped by action and every interaction written as a pathway, and revisions run until the grade lands.